Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors
From MaRDI portal
Publication:6078351
DOI10.1016/J.JTBI.2023.111568zbMath1521.92040OpenAlexW4382753519MaRDI QIDQ6078351
Pranesh Padmanabhan, Narendra M. Dixit
Publication date: 27 September 2023
Published in: Journal of Theoretical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jtbi.2023.111568
mathematical modellingviral kineticsCOVID-19SARS-CoV-2spike proteindrug synergyOmicronCathepsinTMPRSS2
Cites Work
This page was built for publication: Modelling how increased Cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors